302. Role of Inflammatory Markers in Diagnosing Diabetic Foot Infection: A Meta-analysis
Session: Poster Abstract Session: Bone and Joint Infections
Thursday, October 4, 2018
Room: S Poster Hall
  • Poster final .pdf (417.6 kB)
  • Role of Inflammatory Markers in Diagnosing Diabetic Foot Infection: A Meta-analysis


    Diabetic foot ulcers (DFUs) cause significant morbidity and put great economic burden on patient and health care facilities. Infection is the main driving force behind admissions related to DFU. Culture of soft tissue or bone is invaluable in diagnosing infection but is time consuming. Inflammatory markers including erythrocyte sedimentation rate (ESR), C-reactive protein (CRP) and procalcitonin (PCT) are rapid, simple and inexpensive laboratory tests that can aid in early diagnosis of diabetic foot infection (DFI) and monitor response to treatment. We did a meta-analysis to compare diagnostic performance of inflammatory markers for detecting DFI.

    We searched PubMed, Embase and Cochrane databases from their inception to December 2017. This meta-analysis was performed according to PRISMA guidelines. We included studies based on following inclusion criteria (1) At least one of the biomarkers (ESR, CRP, PCT) was evaluated (3) both sensitivity and specificity were measured as outcomes (4) sufficient data was available to construct 2 X 2 contingency table. We used bivariate random effect regression model to pool the sensitivity and specificity of the targeted biomarkers.

    A comprehensive literature search identified a total of 73 studies. 12 studies met our inclusion criteria. Number of studies reporting data on each individual biomarker was as follows: 11 for ESR, 7 for CRP and 5 for PCT. Pooled sensitivity and specificity for ESR were calculated to be 0.84 (95% CI 0.76-0.89) and 0.82 (95%CI 0.73-0.89) with area under receiver operating characteristic curve (AUROC) of 0.90 (95% CI 0.87-0.92). Pooled sensitivity and specificity for CRP were found to be 0.64 (95%CI 0.46-0.80) and 0.87 (95%CI 0.75-0.93) with AUROC of 0.85 (95% CI0.82-0.88). Pooled sensitivity and specificity for PCT were 0.74 (95%CI 0.62-0.83) with AUROC of 0.84 (95%CI 0.81-0.87).

    ESR could be beneficial in ruling out infection in persons who have low suspicion of disease. For those who have high suspicion of disease, PCT could be helpful in ruling in infection. Clinicians should avoid ordering both ESR and CRP because role of CRP is limited. All inflammatory markers need standardization of threshold levels for detecting infection.

    Aneela Majeed, MD1, Adeela Mushtaq, MD2, Ahmad Iftikhar, MD3, Umar Zahid, MD3, Fnu Sagar, MD3, Muhammad Usman, MD3, Muhammad Fraz, MD3 and Mayar Al Mohajer, MD4, (1)Department of Medicine, Division of Infectious Diseases, University of Arizona College of Medicine, Tucson, AZ, (2)University of Arizona, Tuscon, AZ, (3)University of Arizona, Tucson, AZ, (4)Infection Prevention and Control-Bslmc, Baylor College of Medicine, Houston, TX


    A. Majeed, None

    A. Mushtaq, None

    A. Iftikhar, None

    U. Zahid, None

    F. Sagar, None

    M. Usman, None

    M. Fraz, None

    M. Al Mohajer, None

    Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 3rd with the exception of research findings presented at the IDWeek press conferences.